Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №2 (2024) > Clinical case of inhibitor form of hemophilia B in a child

Clinical case of inhibitor form of hemophilia B in a child

Alexandra V. Serezhkina , Irina G. Khmelevskaya , Natalya S. Razinkova , Irina I. Zhiznevskaya , Tatyana A. Minenkova , Tatyana V. Feoktistova , Maxim P. Ivenkov

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Hemophilia B is a hereditary, X-linked recessive disease caused by a violation of plasma homeostasis, resulting from a deficiency or absence of coagulation factor IX (FIX). The cause is a mutation of the Xq27 gene encoding FIX. A serious complication of this pathology is the inhibitory form, clinically manifested by the presence of IgG allo-antibodies neutralizing exogenous FIX. The article describes a clinical case of an inhibitory form of hemophilia B in a 12-year-old child.
Key words: hemophilia B, inhibitory form, children, hematology

About the Author

Alexandra V. Serezhkina 1 , Irina G. Khmelevskaya 2 , Natalya S. Razinkova 2 , Irina I. Zhiznevskaya 2 , Tatyana A. Minenkova 2 , Tatyana V. Feoktistova 3 , Maxim P. Ivenkov 2

1 Kursk State medical university, Kursk, russia;

2 Kursk State medical university, Kursk, Russia;

3 Regional children's clinical Hospital, Kursk, Russia

References

1. dolan G, Benson G, duffy A et al. Haemophilia B: Where are we now and what does the future hold? Blood Rev 2018;32(1):52-60. doI: 10.1016/j.blre.2017.08.007
2. Зозуля Н.И., Чернов В.М., Тарасова И.С., Румянцев А.Г. Нерешенные вопросы оказания медицинской помощи пациентам с ингибиторной формой гемофилии в России. Российский журнал детской гематологии и онкологии. 2019;(2):48–53. doI: 10.21682/2311-1267-2019-6-2-48-53 Zozulya n.I., chernov V.m., Tarasova I.S., rumyantsev A.G. unresolved issues of providing medical care to patients with an inhibitory form of hemophilia in russia. Russian journal of pediatric hematology and oncology. 2019;(2):48-53. doI: 10.21682/2311-1267-2019-6-2-48- 53 (in russian).
3. Goodeve Ac. Hemophilia B: molecular pathogenesis and mutation analysis. J Thromb Haemost. 2015;13(7):1184–95. doI: 10.1111/jth.12958
4. Santoro c, Quintavalle G, castaman G et al. Inhibitors in Hemophilia B. Semin Thromb Hemost. 2018;44(6):578–89. doI: 10.1055/s-0038-1660817
5. Барламов П.Н., Васильева Э.Р., Голубева М.Е. и др. Приобретенная ингибиторная форма гемофилии. Клиническая медицина. 2018;96(4):361-4. doI: 10.18821/0023-2149-2018-96-4-361-364 Barlamov P.n., Vasil'yeva e.r., Golubeva m.Ye. et al. Acquired inhibitory form of hemophilia. Clinical medicine. 2018;96(4):361-4. doI: 10.18821/0023-2149-2018-96-4-361-364 (in russian).
6. Флоринский Д.Б.,Жарков П.А.Современные подходы к лечениюгемофилии.Вопросыгематологии/онкологии и иммунопатологии впедиатрии. 2020;19(3):131-8. doI: 10.24287/1726-1708-2020-19-3-131-138 Florinskiy d.B., Zharkov P.A. modern approaches to the treatment of hemophilia. Issues of hematology/oncology and immunopathology in pediatrics. 2020;19(3):131-8. doI: 10.24287/1726-1708-2020-19-3-131-138 (in russian).

For citation:Serezhkina A.V., Khmelevskaya I.G., Razinkova N.S., Zhiznevskaya I.I., Minenkova T.A., Feoktistova T.V., Ivenkov M.P. Clinical case of inhibitor form of hemophilia B in a child. Clinical analysis in general medicine. 2024; 5 (2): 98–100 (In Russ.). 98–100. DOI: 10.47407/ kr2023.5.2.00395


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru